First-line chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma with or without cetuximab: a single institution experience

Authors :: Naomi Kiyota
Yasuo Ejima
Ryohei Sasaki
Naoki Otsuki
Koichi Morimoto
Ken-ichi Nibu
Hirotaka Shinomiya
Tsutomu Minamikawa
Yoshinori Imamura
Source :: Toukeibu Gan. 42:432-437
Publication Year :: 2016
Publisher :: Japan Society for Head and Neck Cancer, 2016.

Subjects :: Oncology
medicine.medical_specialty
Cetuximab
business.industry
medicine.disease
Head and neck squamous-cell carcinoma
Otorhinolaryngology
Internal medicine
medicine
First line chemotherapy
Single institution
business
medicine.drug

Full Text Access

Tools